Castle Biosciences Inc
NAS:CSTLHealthcareCBOEFTSE:MRUTNASDAQ:NBI$32.17+0.64%At closeAt close · Tue 20 Oct · ≈ AED 118.13 · Market cap $982.62M · Next earnings Mon 2 Nov
EPS: actual vs estimate
Beat (%) vs consensus · next report Mon 2 Nov
Next report
DateMon, 2 Nov 2026
EPS estimate−0.38
Revenue estimate92.1m
Currency—
Last reports
| Report | EPS estimate | EPS actual | EPS surprise | Revenue estimate (m) | Revenue actual (m) | Revenue surprise |
|---|---|---|---|---|---|---|
| 2026-07-30 | −0.41 | −0.07 | +83.3% | 86.2 | 103.5 | +20.1% |
| 2026-05-06 | −0.49 | −0.49 | +0.0% | 79.2 | 84.2 | +6.3% |
| 2026-02-26 | −0.23 | −0.08 | +65.2% | 79.9 | 87.0 | +8.9% |
| 2025-11-03 | −0.34 | −0.02 | +94.1% | 80.4 | 83.0 | +3.3% |
| 2025-08-04 | −0.51 | 0.15 | +129.4% | 68.0 | 86.2 | +26.7% |
| 2025-05-05 | −0.08 | −0.20 | −150.0% | 71.8 | 88.0 | +22.5% |
| 2025-02-27 | −0.04 | 0.32 | +900.0% | 83.9 | 86.3 | +2.9% |
| 2024-11-04 | −0.06 | 0.08 | +233.3% | 80.6 | 85.8 | +6.5% |
| 2024-08-05 | −0.27 | 0.31 | +214.8% | 69.3 | 87.0 | +25.5% |
| 2024-05-02 | −0.37 | −0.09 | +75.7% | 66.2 | 73.0 | +10.2% |
| 2024-02-28 | −0.84 | −0.10 | +88.1% | 56.3 | 66.1 | +17.5% |
| 2023-11-02 | −0.92 | −0.26 | +71.7% | 50.7 | 61.5 | +21.3% |
Currency not supplied by the earnings feedUpdated Thu 30 Jul ·
ⓘ
Surprise is actual minus consensus, as a share of the consensus.
